Ablatherm® - HIFU: A New Perspective In 2007, The Year Of The First Long Term Clinical Results On The Treatment Of Localised Prostate Cancer
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Men's health; Clinical Trials / Drug Trials
Article Date: 13 May 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
UroToday.com - UroToday.com announced today the addition of Ablatherm® - HIFU: A New Perspective in 2007, the Year of the First Long Term Clinical Results on the Treatment of Localised Prostate Cancer to the UroToday.com HIFU (High Intensity Focused Ultrasound) Resource Center. The HIFU resource center includes all current publications, clinical information, clinical trials and media presentations related to HIFU treatment.
The clinical results are presented as follows:
Ablatherm® Long Term Results As A Salvage Option After Radiotherapy Failure By Pr. G. Conti MD, Como, Italy
Ablatherm® Efficiency on Long Term Results By F.J. Murat MD, Lyon, France
Ablatherm® Safety on Long Term Results By A. Blana MD, Regensburg, Germany
PSA Nadir: A Surrogate Marker Of Long-Term Efficacy in HIFU Therapy Localised Prostate Cancer By S. Brown MD, Stockport, UK
Visit the HIFU Resource Center and stay updated on clinical developments in HIFU and Prostate Cancer.
About UroToday UroToday.com attracts more than 45,000 readers monthly. The website covers over 22 urology disease categories and provides the most in depth Urological conference reports available online. UroToday.com is the world leader in delivering a quality, global online publication providing accurate and timely education that is clinically relevant in the practice of Urology. All scientific content is developed by urologists committed to translating research into clinically relevant science, including all genitourinary cancers, pediatric and geriatric urological dysfunctions for urologists, medical oncologists, advanced nurse practitioners and other medical professionals.
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2006 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/70792.php>
APA
http://www.medicalnewstoday.com/releases/70792.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




